Featured on CNBC: Eli Lilly and AbCellera partner up on COVID-19 drugs

“CNBC’s Meg Tirrell speaks with Daniel M. Skovronsky, chief scientific officer at Eli Lilly, about drug company’s partnership with Abcellera on COVIDcampaign-pages/bispecifics/-19 treatment as the coronavirus outbreak spreads in the United States and Europe.”

Read full coverage on CNBC.


Together we can make game-changing discoveries.